FUNCTIONAL MAGNETIC RESONANCE LUNG IMAGING USING INHALED HYPERPOLARISED 129Xe

University of Nottingham1 site in 1 country53 target enrollmentFebruary 2014

ConditionsCOPD IPF

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: COPD
Sponsor: University of Nottingham
Enrollment: 53
Locations: 1
Primary Endpoint: Acquisition of baseline data and images to investigate use of hp129Xe as a diagnostic tool
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study is to investigate the potential value of a novel imaging technique (hyperpolarized 129Xe lung imaging) in the diagnosis and assessment of lung disease in patients with COPD and IPF.

Registry

clinicaltrials.gov

Start Date

February 2014

End Date

December 31, 2021

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Nottingham

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Acquisition of baseline data and images to investigate use of hp129Xe as a diagnostic tool

Time Frame: 4 years

i) Obtain baseline data for each group with matched clinical data (e.g. pulmonary function tests) allowing comparison with existing clinical diagnostic techniques and also determining correlation with disease severity ii) Use the images obtained to set up standard sequencing protocols and define algorithms and inform power calculations for subsequent studies